Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low

BACKGROUND: HER2-low could be found in some patients with triple-negative breast cancer (TNBC). However, its potential impacts on clinical features and tumor biological characteristics in TNBC remain unclear. METHODS: We enrolled 251 consecutive TNBC patients retrospectively, including 157 HER2-low...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xi′e, Yang, Ping, Chen, Songhao, Wei, Gang, Yuan, Lijuan, Yang, Zhenyu, Gong, Li, He, Li, Yang, Lin, Peng, Shujia, Dong, Yanming, He, Xianli, Bao, Guoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061837/
https://www.ncbi.nlm.nih.gov/pubmed/36998014
http://dx.doi.org/10.1186/s13058-023-01639-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061837/
https://www.ncbi.nlm.nih.gov/pubmed/36998014
http://dx.doi.org/10.1186/s13058-023-01639-y

Ejemplares similares